Approval for a new trade name.  The device, as modified, will be marketed under the trade name onguard and is indicated to identify and mark regions of interest (rois) on frontal chest radiographic films from adult males with an increased risk for lung cancer to bring rois to the attention of the radiologist after the initial reading has been completed.  Thus the system assists the radiologist in minimizing observational oversights by identifying areas on the original chest films that may warrant a second review.